HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.

doi:10.1016/j.oraloncology.2019.104488

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.

Oral oncology - 1 Jan 2020

Chatfield-Reed Kate, Gui Shanying, O'Neill Wendi Q, Teknos Theodoros N, Pan Quintin

Abstract excerpt

OBJECTIVE: To determine the influence of high-risk HPV genotype on outcomes in HNSCC patients. MATERIALS AND METHODS: This is a retrospective analysis of The Cancer Genome Atlas HNSCC cohort. RESULTS: Using multivariate Cox regression analysis, we revealed that HPV33+ HNSCC patients have inferior overall survival compared to HPV16+ HNSCC patients independent of anatomical site (HR 3.59, 95% CI 1.58-8.12;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Head and Neck Neoplasms
Share to Human papillomavirus 16
Share to Multivariate Analysis
Share to Papillomaviridae

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Sequence Analysis, RNA

Share to Squamous Cell Carcinoma of Head and Neck

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 31835137
DOI: 10.1016/j.oraloncology.2019.104488
PMCID: PMC7897465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.